CUSIP No. 02083G100 | 13G | Exhibit 99.1 |
AGREEMENT
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Alpine Immune Sciences, Inc.
Dated: August 6, 2020 | ||
OMEGA FUND VI, L.P. | ||
BY: | Omega Fund VI GP, L.P. | |
ITS: | GENERAL PARTNER | |
BY: | Omega Fund VI GP Manager, Ltd. | |
ITS: | GENERAL PARTNER | |
By: | /s/ Anne-Mari Paster | |
Director | ||
OMEGA FUND VI GP, L.P. | ||
BY: | Omega Fund VI GP Manager, Ltd. | |
ITS: | GENERAL PARTNER | |
By: | /s/ Anne-Mari Paster | |
Director | ||
OMEGA FUND VI GP MANAGER, LTD. | ||
By: | /s/ Anne-Mari Paster | |
Director | ||
/s/ * Anne-Mari Paster, as Attorney-in-Fact | ||
Claudio Nessi | ||
/s/ * Anne-Mari Paster, as Attorney-in-Fact | ||
Otello Stampacchia | ||
/s/ Anne-Mari Paster* | ||
Anne-Mari Paster |